Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kronox Lab Sciences's EBIT per Share for the
three
months ended in Jun. 2026 was ₹2.70.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ₹10.52.
During the past 12 months, the average EBIT per Share Growth Rate of Kronox Lab Sciences was 5.60% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 16.30% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 20.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Kronox Lab Sciences's EBIT per Share or its related term are showing as below:
BOM:544187'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 16.3 Med: 21 Max: 28.2
Current: 16.3
During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Kronox Lab Sciences was 28.20% per year. The lowest was 16.30% per year. And the median was 21.00% per year.
BOM:544187's 3-Year EBIT Growth Rate is ranked better than 74.51% of 1338
companies
in the Chemicals industry
Industry Median: -0.9
vs BOM:544187: 16.30
Kronox Lab Sciences (BOM:544187) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Kronox Lab Sciences EBIT per Share Related Terms
Kronox Lab Sciences EBIT per Share Historical Data
* Premium members only.
The historical data trend for Kronox Lab Sciences's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹10.52
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kronox Lab Sciences (BOM:544187) has a EBIT per Share of ₹10.52 as of Jun. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Kronox Lab Sciences and its competitors. According to the industry distribution chart, Kronox Lab Sciences ranks #341 out of 1338 companies in the Chemicals industry, placing it in the top 25.5%.
Is Kronox Lab Sciences' EBIT per Share too high?
Kronox Lab Sciences' current EBIT per Share is ₹10.52. Based on the distribution chart, Kronox Lab Sciences ranks #341 out of 1338 companies in the Chemicals industry, which is above the industry midpoint. Overall, Kronox Lab Sciences has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Kronox Lab Sciences' EBIT per Share compare to LIN and SHW?
According to the Chemicals industry distribution chart, Kronox Lab Sciences ranks #341 out of 1338 companies for EBIT per Share. This puts Kronox Lab Sciences in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Kronox Lab Sciences and its competitors. Kronox Lab Sciences's current EBIT per Share is ₹10.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kronox Lab Sciences stock overvalued right now?
Kronox Lab Sciences (BOM:544187) has a current EBIT per Share of ₹10.52. The current EBIT per Share is ₹10.52. Kronox Lab Sciences' overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Kronox Lab Sciences (BOM:544187), the current EBIT per Share is ₹10.52 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kronox Lab Sciences Ltd manufactures High Purity Speciality Fine Chemicals for diversified end-user industries. The company's Fine inorganic Chemicals are used mainly as reacting agents and raw materials in the manufacturing of Active Pharmaceutical Ingredients; excipients in pharmaceutical formulations; reagents for scientific research and laboratory testing; ingredients in nutraceuticals formulations; process intermediates and fermenting agents in biotech applications; ingredients in agrochemical formulations; ingredients in personal care products; refining agents in metal refineries; and ingredients in animal health products, amongst others.
43GF Score
Get the complete analysis for BOM:544187
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544187 has been successfully added to your 
